Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
23.99
-0.31 (-1.28%)
Dec 20, 2024, 4:00 PM EST - Market closed
Dyne Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Dyne Therapeutics stock have an average target of 51.18, with a low estimate of 35 and a high estimate of 66. The average target predicts an increase of 113.34% from the current stock price of 23.99.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DYN stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 3 | 4 | 5 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Initiates $46 | Buy | Initiates | $46 | +91.75% | Dec 13, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $45 | Buy | Initiates | $45 | +87.58% | Nov 26, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $50 | Strong Buy | Maintains | $50 | +108.42% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +129.26% | Nov 13, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $43 → $35 | Buy → Hold | Downgrades | $43 → $35 | +45.89% | Oct 24, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
618.63K
EPS This Year
-3.48
from -3.95
EPS Next Year
-3.89
from -3.48
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 5.1M | 34.4M | |||
| Avg | n/a | 618,625 | 11.3M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 5,467.0% | |||
| Avg | - | - | 1,721.6% | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -3.27 | -3.50 | -3.48 | |||
| Avg | -3.48 | -3.89 | -3.92 | |||
| Low | -3.73 | -4.53 | -4.69 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.